Mentholated insulin is a fast-acting insulin analog and is used to treat diabetes. The amount of Mentholatum insulin needed varies from person to person and should be decided by the doctor based on the patient’s condition. It is usually 0.5 to 1 unit per kilogram of body weight. In treatments targeting mealtimes, about 50% to 70% of this insulin requirement is provided by meningococcal insulin, with the rest being provided by intermediate- or long-acting insulin. Note that this drug is contraindicated in patients who are hypersensitive to menopausal insulin or any other ingredient in this product and during hypoglycemic episodes. Hypoglycemia is the most common adverse reaction to treatment with this product, and relatively rare adverse reactions such as rash and allergic reactions may also occur. Seek medical attention if you feel unwell after using the drug. Patients with diabetes mellitus should formulate an individualized medication plan under the guidance of a specialist physician, and standardize the use of insulin and regularly monitor blood glucose under the guidance of a physician.